Barbara Jereczek-Fossa to Male
This is a "connection" page, showing publications Barbara Jereczek-Fossa has written about Male.
Connection Strength
0.247
-
COVID-19 impact in radiotherapy practice in an oncology hub: a screenshot from Lombardy, Italy. Tumori. 2021 Dec; 107(6):498-503.
Score: 0.012
-
Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy. Head Neck. 2020 Jul; 42(7):1482-1490.
Score: 0.012
-
Radiotherapy for oligometastatic cancer: a survey among radiation oncologists of Lombardy (AIRO-Lombardy), Italy. Radiol Med. 2019 Apr; 124(4):315-322.
Score: 0.011
-
Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer. Med Oncol. 2018 Nov 27; 36(1):9.
Score: 0.011
-
Stereotactic body radiation therapy for mediastinal lymph node metastases: how do we fly in a 'no-fly zone'? Acta Oncol. 2018 Nov; 57(11):1532-1539.
Score: 0.011
-
Nutritional Intervention for Nonsurgical Head and Neck Cancer Patients Treated with Radiation Therapy: Results from a Prospective Stepped-Wedge Clinical Protocol. Nutr Cancer. 2018 10; 70(7):1051-1059.
Score: 0.011
-
Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation. Radiol Med. 2019 Jan; 124(1):65-78.
Score: 0.011
-
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer. Radiother Oncol. 2018 08; 128(2):315-320.
Score: 0.010
-
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218. Br J Radiol. 2018 Sep; 91(1089):20160725.
Score: 0.010
-
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach. Med Oncol. 2018 May 10; 35(6):96.
Score: 0.010
-
Radiotherapy Plus Total Androgen Block Versus Radiotherapy Plus LHRH Analog Monotherapy for Non-metastatic Prostate Cancer. Anticancer Res. 2018 05; 38(5):3139-3143.
Score: 0.010
-
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases. Med Oncol. 2018 Apr 18; 35(5):75.
Score: 0.010
-
Radiotherapy in patients with cardiac implantable electronic devices: clinical and dosimetric aspects. Med Oncol. 2018 Apr 17; 35(5):73.
Score: 0.010
-
Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT. Med Oncol. 2018 Mar 28; 35(5):59.
Score: 0.010
-
CyberKnife radiotherapy for orbital metastases: A single-center experience on 24 lesions. Eur J Ophthalmol. 2019 Jan; 29(1):61-68.
Score: 0.010
-
Cone-beam CT-based inter-fraction localization errors for tumors in the pelvic region. Phys Med. 2018 Feb; 46:59-66.
Score: 0.010
-
Radiation-induced acute dysphagia : Prospective observational study on 42 head and neck cancer patients. Strahlenther Onkol. 2017 Nov; 193(11):971-981.
Score: 0.010
-
Can the Day 0 CT-scan predict the post-implant scanning? Results from 136 prostate cancer patients. Phys Med. 2017 Aug; 40:66-71.
Score: 0.010
-
Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression. Med Oncol. 2017 Jun; 34(6):107.
Score: 0.010
-
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes. Clin Genitourin Cancer. 2017 08; 15(4):e623-e632.
Score: 0.009
-
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO). Crit Rev Oncol Hematol. 2019 Jun; 138:24-28.
Score: 0.003
-
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. World J Urol. 2019 Dec; 37(12):2631-2637.
Score: 0.003
-
The European Prostate Cancer Centres of Excellence: A Novel Proposal from the European Association of Urology Prostate Cancer Centre Consensus Meeting. Eur Urol. 2019 08; 76(2):179-186.
Score: 0.003
-
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey. Radiol Med. 2019 Mar; 124(3):211-217.
Score: 0.003
-
GUROPA survey: genito-urinary radiation oncology prescription attitudes. Radiol Med. 2018 Nov; 123(11):879-884.
Score: 0.003
-
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer. World J Urol. 2019 Dec; 37(12):2607-2613.
Score: 0.003
-
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study. Eur Urol Focus. 2019 11; 5(6):1007-1013.
Score: 0.003
-
Multimodal image registration for the identification of dominant intraprostatic lesion in high-precision radiotherapy treatments. Br J Radiol. 2017 Nov; 90(1079):20170021.
Score: 0.002
-
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study. Prostate. 2017 Jul; 77(10):1160-1166.
Score: 0.002
-
High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy Approach. Clin Genitourin Cancer. 2017 06; 15(3):376-383.
Score: 0.002
-
Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients. Tumori. 2017 May 12; 103(3):314-318.
Score: 0.002
-
The emerging role of obesity, diet and lipid metabolism in prostate cancer. Future Oncol. 2017 Feb; 13(3):285-293.
Score: 0.002
-
Robot-assisted radical prostatectomy: Multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins. Radiology. 2015 Feb; 274(2):434-44.
Score: 0.002
-
The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer. Radiol Med. 2013 Jun; 118(4):660-78.
Score: 0.002
-
Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use. Strahlenther Onkol. 2009 Jun; 185(6):384-9.
Score: 0.001
-
Endoscopic CO2 laser surgery for early glottic cancer in patients who are candidates for radiotherapy: results of a prospective nonrandomized study. Head Neck. 2006 Feb; 28(2):121-5.
Score: 0.001